X4 Pharmaceuticals (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- December 14, 2015
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $37,500,000
Company Info
- Founders
- Alan Walts
- Company Description
- X4 Pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking and increase the ability for T-Cells to track and destroy cancer cells. The company's oral small molecule drug candidates inhibit the CXCR4 receptor, a pathway which plays a central role in promoting the immunosuppressive and pro-angiogenic microenvironment of many cancers.
- Market
- Oncology
- Location
- Cambridge, MA, USA
- Coinvestors
- Cormorant Asset Management, Maxim Group